Explore 3 Stock Ideas & Industry Insights Download Free Report
Futura Medical, quoted on AIM since 2003, develops sexual health products based on topically delivered gel formulations. Its lead product is Eroxon, a gel for erectile dysfunction, which is sold in the US through partners and earns royalties. Its pipeline includes Eroxon Intense, which …
The shares have had a volatile 12 months, trading in a 52-week range of roughly 1,300p to 3,020p, so the run-up to results is a period when buyers and sellers are particularly active.
CelLBxHealth's Parsortix platform captures circulating tumour cells, or CTCs, from a simple blood sample. These cells can reveal how a cancer is behaving and responding to treatment, making the technology valuable for research,Drug Developmentand clinical oncology.
The continued buying suggests investors increasingly view Diaceutics as a scalable, high-margin data and services platform at an inflection point in recurring revenue.
• October puts the UK health care sector in focus as investors reassessEarningsresilience against higher gilt yields,Inflationrisk and the approaching UK Budget.
• Cambridge Nutritional Sciences Plc (LSE:CNSL) advanced 9.68% on 2 October 2026, putting the stock among the stronger movers in the session.
• EDX Medical Group PLC (LSE:EDX) advanced 8.57% on 2 October 2026, putting the stock among the stronger movers in the session.
• ValiRx Plc (LSE:VAL) advanced 11.11% on 2 October 2026, putting the stock among the stronger movers in the session.
• Verici Dx Plc (LSE:VRCI) advanced 7.14% on 2 October 2026, putting the stock among the stronger movers in the session.
There was no fresh announcement from the company on the day. Instead, the rally looks like continued investor support following its interim results on 9 September, after the shares had closed at around 490 pence on 30 September.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…